摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N,N'-Bis-methoxyacetyl-ethylendiamin | 90222-14-3

中文名称
——
中文别名
——
英文名称
N,N'-Bis-methoxyacetyl-ethylendiamin
英文别名
N,N'-(ethane-1,2-diyl)bis(2-methoxyacetamide);2-methoxy-N-[2-[(2-methoxyacetyl)amino]ethyl]acetamide
N,N'-Bis-methoxyacetyl-ethylendiamin化学式
CAS
90222-14-3
化学式
C8H16N2O4
mdl
MFCD24388975
分子量
204.226
InChiKey
FZFCCBJGFXRQBK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.4
  • 重原子数:
    14
  • 可旋转键数:
    7
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    76.7
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    N,N'-Bis-methoxyacetyl-ethylendiamin[RuH(CO)(BPy-tPNN*)]氢气 作用下, 以 四氢呋喃 为溶剂, 110.0 ℃ 、1.01 MPa 条件下, 反应 48.0h, 以78%的产率得到乙二醇甲醚
    参考文献:
    名称:
    温和条件下酰胺直接加氢生成醇和胺
    摘要:
    发现了酰胺选择性直接氢化成相应的醇和胺,同时 CN 键断裂。没有形成预期的 CO 裂解产物(在苯胺的情况下痕量除外)。该反应在温和的压力和中性、均相条件下使用脱芳构化的联吡啶基 PNN Ru(II) 钳形络合物作为催化剂进行。假设的机制涉及通过杂芳族钳核的芳构化-脱芳构化的金属-配体合作,并且不涉及酰胺的水解裂解。这种对环境无害的方法的简单性、通用性和效率使其对酰胺直接转化为醇和胺具有很好的收率。
    DOI:
    10.1021/ja1080019
  • 作为产物:
    参考文献:
    名称:
    Baganz,H. et al., Chemische Berichte, 1962, vol. 95, p. 1832 - 1839
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • PROCESS FOR PREPARING AMIDES FROM ALCOHOLS AND AMINES
    申请人:MILSTEIN David
    公开号:US20090112005A1
    公开(公告)日:2009-04-30
    The present invention provides a process for preparing amides, by reacting a primary amine and a primary alcohol in the presence of a Ruthenium catalyst, to generate the amide and molecular hydrogen. According to the process of the invention, primary amines are directly acylated by equimolar amounts of alcohols to produce amides and molecular hydrogen (the only byproduct) in high yields and high turnover numbers. This reaction is catalyzed by a Ruthenium complex, which is preferably based on a dearomatized PNN-type ligand of formula A1 or precursors thereof of formulae A2 or A3. Use of diamines in the reaction leads to bis-amides, whereas with a mixed primary/secondary amine substrate, chemoselective acylation of the primary amine group occurs.
    本发明提供了一种制备酰胺的方法,通过在Ruthenium催化剂的存在下反应一种一级胺和一种一级醇,生成酰胺和分子氢。根据本发明的方法,一级胺通过等摩尔量的醇直接酰化产生酰胺和分子氢(唯一的副产物),产率高,周转数高。这种反应由Ruthenium配合物催化,最好是基于公式A1的去芳香PNN型配体或其前体公式A2或A3。在反应中使用二胺会导致双酰胺,而使用混合的一级/二级胺底物,会发生一级胺基的化学选择性酰化。
  • USE OF RUTHENIUM COMPLEXES FOR FORMATION AND/OR HYDROGENATION OF AMIDES AND RELATED CARBOXYLIC ACID DERIVATIVES
    申请人:Milstein David
    公开号:US20120253042A1
    公开(公告)日:2012-10-04
    A process for preparing amides by reacting a primary amine and a primary alcohol in the presence of a Ruthenium complex to generate the amide and molecular hydrogen. Primary amines are directly acylated by equimolar amounts of alcohols to produce amides and molecular hydrogen (the only byproduct) in high yields and high turnover numbers. Also disclosed are processes for hydrogenation of amides to alcohols and amines; hydrogenation of organic carbonates to alcohols; hydrogenation of carbamates or urea derivatives to alcohols and amines; amidation of esters; acylation of alcohols using esters; coupling of alcohols with water and a base to form carboxylic acids; dehydrogenation of beta-amino alcohols to form pyrazines and cyclic dipeptides; and dehydrogenation of secondary alcohols to ketones. These reactions are catalyzed by a Ruthenium complex which is based on a dearomatized PNN-type ligand of formula A1 or precursors thereof of formulae A2 or A3.
    一种制备酰胺的方法,包括在Ruthenium配合物的存在下,通过反应一种一级胺和一种一级醇生成酰胺和分子氢。直接用等摩尔量的醇对一级胺进行酰化反应,可以高产率、高周转数地生成酰胺和分子氢(唯一的副产物)。此外,还揭示了将酰胺氢化为醇和胺的方法;将有机碳酸酯氢化为醇的方法;将氨基甲酸酯或尿素生物氢化为醇和胺的方法;酯的酰胺化反应;使用酯对醇进行酰化反应;将醇与和碱偶联形成羧酸;将β-基醇脱氢生成吡嗪和环肽;以及将二级醇脱氢生成酮的方法。这些反应由基于A1式或A2式或A3式的去芳香的PNN型配体的Ruthenium配合物催化。
  • Synthetic Multimerizing Agents
    申请人:Holt Dennis A.
    公开号:US20120130076A1
    公开(公告)日:2012-05-24
    New compounds are disclosed for multimerizing immunophilins and proteins containing immunophilin or immunophilin-related domains. The compounds are of the formula M-L-Q where M is a synthetic ligand for an FKBP protein.
    新化合物被披露用于多聚免疫蛋白和含有免疫蛋白或免疫蛋白相关域的蛋白质。这些化合物的化学式为M-L-Q,其中M是FKBP蛋白的合成配体
  • NOVEL RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF
    申请人:Milstein David
    公开号:US20130281664A1
    公开(公告)日:2013-10-24
    The present invention relates to novel Ruthenium catalysts and related borohydride complexes, and the use of such catalysts, inter alia, for (1) hydrogenation of amides (including polyamides) to alcohols and amines; (2) preparing amides from alcohols with amines (including the preparation of polyamides (e.g., polypeptides) by reacting dialcohols and diamines and/or by polymerization of amino alcohols); (3) hydrogenation of esters to alcohols (including hydrogenation of cyclic esters (lactones) or cyclic di-esters (di-lactones) or polyesters); (4) hydrogenation of organic carbonates (including polycarbonates) to alcohols and hydrogenation of carbamates (including polycarbamates) or urea derivatives to alcohols and amines; (5) dehydrogenative coupling of alcohols to esters; (6) hydrogenation of secondary alcohols to ketones; (7) amidation of esters (i.e., synthesis of amides from esters and amines); (8) acylation of alcohols using esters; (9) coupling of alcohols with water to form carboxylic acids; and (10) dehydrogenation of beta-amino alcohols to form pyrazines. The present invention further relates to the novel uses of certain pyridine Ruthenium catalysts.
    本发明涉及新型催化剂和相关氢化物配合物,以及使用这些催化剂,包括:(1)将酰胺(包括聚酰胺)加氢为醇和胺;(2)用胺从醇制备酰胺(包括通过二元醇和二胺反应或基醇聚合制备聚酰胺(例如聚肽));(3)将酯加氢为醇(包括环酯(内酯)或环二酯(二内酯)或聚酯的加氢);(4)将有机碳酸酯(包括聚碳酸酯)加氢为醇和将氨基甲酸酯(包括聚氨基甲酸酯)或生物加氢为醇和胺;(5)醇的脱氢缩合成酯;(6)将二级醇加氢为酮;(7)酯的酰胺化(即从酯和胺合成酰胺);(8)使用酯对醇进行酰化;(9)将醇与偶联形成羧酸;以及(10)β-基醇的脱氢缩合形成吡嗪的新用途。本发明还涉及某些吡啶催化剂的新用途。
  • SYNTHETIC DERIVATIVES OF RAPAMYCIN AS MULTIMERIZING AGENTS FOR CHIMERIC PROTEINS WITH IMMUNOPHILIN-DERIVED DOMAINS
    申请人:ARIAD Pharmaceuticals, Inc
    公开号:EP0888303B1
    公开(公告)日:2010-04-21
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸